Patent · US Active

Nucleic acid encoding TNFx protein

US8148507B2 · kind B2 · utility

13Cited by

1References

7Claims

0Family size

Assignee

SCHERING CORPORATION · US

Inventors

Christi L. Parham · Menlo Park, US
Daniel M. Gorman · Newark, US
Hirokazu Kurata · Kobe, JP
Naoko Arai · Tokyo, JP
Theodore R. Sana · Santa Clara, US
Jeanine D. Mattson · San Francisco, US
Erin Murphy · Redwood City, US
Chetan Savkoor · San Jose, US
Jeffery Grein · Cupertino, US
Kathleen Smith · Palo Alto, US
Terrill K. McClanahan · Sunnyvale, US

Key dates

Filing date	Dec 21, 2010
Grant date	Apr 3, 2012
Priority date	—
Expiry date	Dec 21, 2030

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S435/975
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Nucleic acids encoding mammalian, e.g., primate or rodent, genes, purified proteins and fragments thereof. Antibodies, both polyclonal and monoclonal, are also provided. Methods of using the compositions for both diagnostic and therapeutic utilities are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.